Selective thromboxane synthetase inhibitor and ischemic heart disease

Biomed Biochim Acta. 1984;43(8-9):S125-32.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Acrylates / therapeutic use*
  • Adult
  • Angina Pectoris / drug therapy
  • Angina Pectoris / physiopathology*
  • Female
  • Humans
  • Male
  • Methacrylates / therapeutic use*
  • Middle Aged
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / physiopathology*
  • Oxidoreductases / antagonists & inhibitors*
  • Physical Exertion
  • Platelet Aggregation / drug effects
  • Reference Values
  • Thromboxane B2 / blood
  • Thromboxane-A Synthase / antagonists & inhibitors*

Substances

  • Acrylates
  • Methacrylates
  • Thromboxane B2
  • 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid
  • Oxidoreductases
  • Thromboxane-A Synthase
  • ozagrel